Treatment of Failing Blebs With Ranibizumab

NCT00570726 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Glaucoma, Open-Angle
Failing Bleb Following Trabeculectomy

Interventions

DRUG: Ranibizumab (Lucentis)

Sponsor

The New York Eye & Ear Infirmary

Collaborators

[object Object]